Skip to main content
. 2025 Jun 20;312(3):919–925. doi: 10.1007/s00404-025-08084-6

Table 3.

Perioperative parameters of the study population

Variables Proliferative phase (n = 80) Secretory phase (n = 63) P value
Combined pelvic endometriosis surgery 16 (20.0%) 14 (22.2%) 0.746
Intraoperative lesion location 0.061
 Uterine fundus 16 (20.0%) 5 (7.9%)
 Anterior uterine wall 8 (10.0%) 12 (19%)
 Posterior uterine wall 56 (70.0%) 46 (73.0%)
Operation time (min) 144.88 ± 42.99 137.34 ± 45.51 0.313
Estimated blood loss (ml) 67.75 ± 118.76 72.07 ± 76.88 0.803
Perioperative complications 0 3 (4.8%) 0.093
Postoperative hospital stay (days) 3.58 ± 2.45 3.65 ± 1.36 0.815

The values are presented as mean ± standard or number (percentage)

*P < 0.05, **P < 0.01, ***P < 0.001